Patents by Inventor Luc Aujame

Luc Aujame has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8309100
    Abstract: The invention concerns nucleic acids coding for polypeptides specific of the Neisseria genus pathogenic strains, the corresponding polypeptides, and their diagnostic and therapeutic applications.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: November 13, 2012
    Assignees: Aventis Pasteur, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Luc Aujame, Annabelle Bouchardon, Geneviève Renauld-Mongenie, Bachra Rokbi, Xavier Nassif, Colin Tinsley, Agnès Perrin
  • Publication number: 20100184639
    Abstract: The invention concerns nucleic acids coding for polypeptides specific of the Neisseria genus pathogenic strains, the corresponding polypeptides, and their diagnostic and therapeutic applications.
    Type: Application
    Filed: February 4, 2010
    Publication date: July 22, 2010
    Inventors: Luc AUJAME, Annabelle Bouchardon, Geneviève Renauld-Mongenie, Bachra Rokbi, Xavier Nassif, Colin Tinsley, Agnes Perrin
  • Patent number: 7704513
    Abstract: The invention concerns nucleic acids coding for polypeptides specific of the Neisseria genus pathogenic strains, the corresponding polypeptides, and their diagnostic and therapeutic applications.
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: April 27, 2010
    Assignees: Aventis Pasteur, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Luc Aujame, Annabelle Bouchardon, Geneviève Renauld-Mongenie, Bachra Rokbi, Xavier Nassif, Colin Tinsley, Agnès Perrin
  • Publication number: 20090155886
    Abstract: The invention concerns nucleic acids coding for polypeptides specific of the Neisseria genus pathogenic strains, the corresponding polypeptides, and their diagnostic and therapeutic applications.
    Type: Application
    Filed: March 27, 2008
    Publication date: June 18, 2009
    Inventors: Luc AUJAME, Annabelle Bouchardon, Genevieve Renauld-Mongenie, Bachra Rokbi, Xavier Nassif, Colin Tinsley, Agnes Perrin
  • Patent number: 7384768
    Abstract: The invention concerns nucleic acids coding for polypeptides specific of the Neisseria genus pathogenic strains, the corresponding polypeptides, and their diagnostic and therapeutic applications.
    Type: Grant
    Filed: August 3, 2004
    Date of Patent: June 10, 2008
    Assignees: Aventis Pasteur, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Luc Aujame, Annabelle Bouchardon, Geneviève Renauld-Mongenie, Bachra Rokbi, Xavier Nassif, Colin Tinsley, Agnès Perrin
  • Publication number: 20050032103
    Abstract: The invention concerns nucleic acids coding for polypeptides specific of the Neisseria genus pathogenic strains, the corresponding polypeptides, and their diagnostic and therapeutic applications.
    Type: Application
    Filed: August 3, 2004
    Publication date: February 10, 2005
    Inventors: Luc Aujame, Annabelle Bouchardon, Genevieve Renauld-Mongenie, Bachra Rokbi, Xavier Nassif, Colin Tinsley, Agnes Perrin
  • Patent number: 6835384
    Abstract: The invention concerns nucleic acids coding for polypeptides specific of the Neisseria genus pathogenic strains, the corresponding polypeptides, and their diagnostic and therapeutic applications.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: December 28, 2004
    Assignees: Aventis Pasteur, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Luc Aujame, Annabelle Bouchardon, Geneviève Renauld-Mongenie, Bachra Rokbi, Xavier Nassif, Colin Tinsley, Agnès Perrin
  • Publication number: 20040170646
    Abstract: The present invention relates to methods for producing ALVAC virus on avian embryonic stem cells and compositions comprising ALVAC virus made using such methods.
    Type: Application
    Filed: December 12, 2003
    Publication date: September 2, 2004
    Applicant: Aventis Pasteur, Inc.
    Inventors: Veronique Barban, Luc Aujame
  • Patent number: 6599697
    Abstract: On the basis of a first repertoire of genes coding for a population of one of two kinds of polypeptides capable of being combined, particularly an antibody light chain variable region, and at least one gene, and preferably a second repertoire coding for the other kind of polypeptide, particularly an antibody heavy chain variable region, the genes from the first repertoire are inserted into a first vector to form a vector population and the genes from the second repertoire are inserted into a second vector, at least one of said vectors being a recipient for the expression of both genes as polypeptides irreversibly combined with the outer surface of the product of said vector.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: July 29, 2003
    Assignee: Pasteur Merieux Serums et Vaccins
    Inventors: Regis Sodoyer, Luc Aujame, Frederique Geoffroy
  • Patent number: 6174708
    Abstract: On the basis of a first repertoire of genes coding for a population of one of two kinds of polypeptides capable of being optionally covalently combined, particularly variable regions of either the antibody light chain type or the antibody heavy chain type, and at least one gene coding for the other type of polypeptide, particularly a variable region of the other type, an antibody chain or preferably a second repertoire of genes coding for a population of said other type, the genes from the first repertoire are inserted into a first vector to form a population of vectors carrying the various genes of said first repertoire, and said gene of said other type or the genes from said second repertoire is/are inserted into a second vector. Both starting vectors have means enabling each to exchange one part by one or more irreversible recombinations to generate recombinant final vectors of which one contains a gene of one of said types and a gene of the other type.
    Type: Grant
    Filed: January 22, 1999
    Date of Patent: January 16, 2001
    Assignee: Pasteur Merieux Serums & Vaccins
    Inventors: Regis Sodoyer, Luc Aujame, Fr{acute over (e)}d{acute over (e)}rique Geoffroy, Annabelle Bouchardon